Paliperidone regulates intracellular redox system in rat brain: Role of purine mechanism


DEMİRCİ K., ÖZÇANKAYA R., Yilmaz H. , YİĞİT A., UĞUZ A. C. , KARAKUŞ K., et al.

REDOX REPORT, cilt.20, ss.170-176, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objective: The treatment of schizophrenia is multifactorial, with antipsychotic medications comprising a major part of treatment. Paliperidone is a newly commercialized antipsychotic whose formulation includes the principal active metabolite risperidone, 9-hydroxyrisperidone. Ever since the relationship between schizophrenia and oxidative stress was first demonstrated, many studies have been conducted in order to probe the potential protective effects of antipsychotic drugs on the oxidant-antioxidant system and lipid peroxidation. The basic aim of this study is to determine the effects of the newly marketed drug paliperidone on the activities of the enzymes adenosine deaminase (ADA), xanthine oxidase (XO), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) as well as on malondialdehyde (MDA) and nitric oxide (NO) levels in rat brain tissues.